
Sign up to save your podcasts
Or


There is no question that the COVID-19 pandemic has impacted every U.S. industry. As the healthcare industry faced new and unprecedented challenges and focused on serving patients, healthcare M&A activity took a pause, but has rebounded quickly. In this discussion, hear TripleTree professionals and industry leaders discuss what types of deals are on the horizon, the metrics shaping the deals themselves, and tips on how both how strategic acquirers and private equity investors can effectively evaluate and compete to win on high quality M&A opportunities in the near-term.
Discussion Leaders
Copyright © 2020 TripleTree Holdings, LLC. All rights reserved.
By TripleTreeThere is no question that the COVID-19 pandemic has impacted every U.S. industry. As the healthcare industry faced new and unprecedented challenges and focused on serving patients, healthcare M&A activity took a pause, but has rebounded quickly. In this discussion, hear TripleTree professionals and industry leaders discuss what types of deals are on the horizon, the metrics shaping the deals themselves, and tips on how both how strategic acquirers and private equity investors can effectively evaluate and compete to win on high quality M&A opportunities in the near-term.
Discussion Leaders
Copyright © 2020 TripleTree Holdings, LLC. All rights reserved.